Gain Therapeutics Inc —— 资产负债表 (NASDAQ:GANX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 38.99 M24.1 M18.61 M12.12 M22.82 M 负债总额 4.17 M5.22 M6.03 M4.78 M4.25 M 权益总额 34.82 M18.88 M12.58 M7.34 M18.56 M 负债及股东权益总额 38.99 M24.1 M18.61 M12.12 M22.82 M 总债务 694.29 K603.39 K567.85 K438.5 K400.95 K 净债务 -36.19 M-19.54 M-16.23 M-9.95 M-20.44 M

新闻

Gain Therapeutics报告帕金森氏症生物标志物减少81%

Gain Therapeutics reports 81% reduction in Parkinson’s biomarker

Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - BioAtla (NASDAQ:BCAB), ChowChow Cloud Internatio (AMEX:CHOW)

Gain Therapeutics (GANX) Upgraded to Buy: Here's Why

Roth/MKM上调Gain Therapeutics股票目标价至10美元，源于积极试验数据

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

美国股市上涨；截至收盘道琼斯工业平均指数上涨0.14%

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy

H.C. Wainwright在试验数据发布前重申对Gain Therapeutics股票的买入评级

H.C. Wainwright reiterates Buy rating on Gain Therapeutics stock ahead of trial data

Gain Therapeutics提交招股说明书补充文件进行3550万美元股票发行